State Street’s Silo Pharma SILO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-833
Closed -$4.5K 4262
2026
Q1
$4.5K Hold
833
﹤0.01% 4263
2025
Q4
$4.25K Hold
833
﹤0.01% 4283
2025
Q3
$8.63K Hold
833
﹤0.01% 4271
2025
Q2
$7.88K Hold
833
﹤0.01% 4246
2025
Q1
$14.6K Hold
833
﹤0.01% 4235
2024
Q4
$11.1K Hold
833
﹤0.01% 4273
2024
Q3
$13.8K Hold
833
﹤0.01% 4249
2024
Q2
$12.1K Hold
833
﹤0.01% 4313
2024
Q1
$24K Hold
833
﹤0.01% 4276
2023
Q4
$18K Hold
833
﹤0.01% 4351
2023
Q3
$20.6K Hold
833
﹤0.01% 4436
2023
Q2
$25.4K Hold
833
﹤0.01% 4562
2023
Q1
$26.2K Buy
+833
New +$30.4K ﹤0.01% 4647

Other funds holding SILO

State Street's SILO Position: Q2 2026 in Review

State Street sold out of Silo Pharma (SILO) in Q2 2026, closing a stake of 833 shares — an estimated $4.5K sold.

State Street first reported a position in SILO in Q1 2023 and held it in 13 quarters. The position peaked at $26.2K in Q1 2023. 9 funds tracked by Wall St. Rank hold SILO as of Q2 2026.

  • State Street reported no remaining Silo Pharma position as of Q2 2026 after selling out during the quarter.
  • State Street sold 833 Silo Pharma shares in Q2 2026, an estimated $4.5K.
  • State Street first reported a position in Silo Pharma in Q1 2023 and held it in 13 quarters.
  • State Street's Silo Pharma position peaked at $26.2K in Q1 2023.
  • 9 funds tracked by Wall St. Rank held Silo Pharma as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.